[go: up one dir, main page]

CY1114962T1 - IMMUNIZATION USING CELLULAR FLOWER CELLS - Google Patents

IMMUNIZATION USING CELLULAR FLOWER CELLS

Info

Publication number
CY1114962T1
CY1114962T1 CY20141100184T CY141100184T CY1114962T1 CY 1114962 T1 CY1114962 T1 CY 1114962T1 CY 20141100184 T CY20141100184 T CY 20141100184T CY 141100184 T CY141100184 T CY 141100184T CY 1114962 T1 CY1114962 T1 CY 1114962T1
Authority
CY
Cyprus
Prior art keywords
immunization
cellular
cells
cell populations
flower cells
Prior art date
Application number
CY20141100184T
Other languages
Greek (el)
Inventor
Casper Paludan
James Edinger
Ryhor Harbacheuski
Roseann Murray
Robert J Hariri
Original Assignee
Anthrogenesis Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06816901.0A external-priority patent/EP1957633B1/en
Application filed by Anthrogenesis Corporation filed Critical Anthrogenesis Corporation
Publication of CY1114962T1 publication Critical patent/CY1114962T1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μεθόδους ανοσοδιαμόρφωσης χρησιμοποιώντας πλακουντιακά βλαστικά κύτταρα και πλακουντιακούς πληθυσμούς βλαστικών κυττάρων. Η εφεύρεση παρέχει επίσης μεθόδους παραγωγής και επιλογής πλακουντιακών κυττάρων και κυτταρικών πληθυσμών βάσει ανοσοδιαμόρφωσης, και συνθέσεων που περιλαμβάνουν τέτοια κύτταρα και κυτταρικούς πληθυσμούς.The present invention provides methods of immunomodulation using placental stem cells and placental stem cell populations. The invention also provides methods for producing and selecting placental cells and cell populations based on immunomodulation, and compositions comprising such cells and cell populations.

CY20141100184T 2005-10-13 2014-03-07 IMMUNIZATION USING CELLULAR FLOWER CELLS CY1114962T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72700405A 2005-10-13 2005-10-13
US83562806A 2006-08-04 2006-08-04
EP06816901.0A EP1957633B1 (en) 2005-10-13 2006-10-13 Immunomodulation using placental stem cells

Publications (1)

Publication Number Publication Date
CY1114962T1 true CY1114962T1 (en) 2016-12-14

Family

ID=58464037

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100184T CY1114962T1 (en) 2005-10-13 2014-03-07 IMMUNIZATION USING CELLULAR FLOWER CELLS

Country Status (1)

Country Link
CY (1) CY1114962T1 (en)

Similar Documents

Publication Publication Date Title
MX2021015070A (en) Immunomodulation using placental stem cells.
MX2009001311A (en) Tumor suppression using placental stem cells.
CY1119106T1 (en) ANTIBODIES AGAINST MASP-2
TW200732349A (en) Anti-OX40L antibodies and methods using same
NO20062709L (en) Stem cells suitable for transplantation, preparation thereof and pharmaceutical preparations comprising said stem cells
ATE427965T1 (en) ANTIBODIES AGAINST 25-HYDROXYVITAMIN D
ATE541857T1 (en) OPTIMIZED FC VARIANTS AND MANUFACTURING PROCESSES THEREOF
DK1940918T3 (en) Dimercaptan terminated polythioether polymers and processes for preparing and using the same
TW200720232A (en) Crystalline solid forms of tigecycline and methods of preparing same
ATE489465T1 (en) TARGETED INTEGRATION INTO THE PPP1R12C POSITION
EA200702643A1 (en) TWEAK ANTIBODIES
MX336807B (en) Compositions and methods for producing a composition.
NZ595786A (en) Placental stem cell populations
ATE528989T1 (en) CRYSTALLINE SOLID RASAGILIN BASE
UA99700C2 (en) A METHOD OF PREPARING AN IMMORTALIZED HUMAN CELL LINE
MX341370B (en) Humanized anti-beta7 antagonists and uses therefor.
NO20071309L (en) Method of expansion
NO20090047L (en) Anti-DLL4 antibodies and methods for their use
TW200715634A (en) Stable organic devices
DK1557462T3 (en) Graft Acceptor-Inducing Cells of Monocytic Origin, Their Preparation and Use
AU2019268061A1 (en) Placental stem cell populations
EA200701293A1 (en) THERAPEUTIC COMPOSITION OF THE GROWTH FACTOR OF KERATINOCYTES
EA200801573A1 (en) METHOD FOR OBTAINING CRYSTALLINE FORMS OF ORLISTAT
TW200716130A (en) Purified form of tanaproget
TW200630348A (en) Tadalafil crystal forms and processes for preparing them